This list is based on the watchlists of people on Stock Events who follow TMCI. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Show more...
FAQ
What is Treace Medical Concepts stock price today?▼
The current price of TMCI is $4.46 USD — it has increased by +0.45% in the past 24 hours. Watch Treace Medical Concepts stock price performance more closely on the chart.
What is Treace Medical Concepts stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Treace Medical Concepts stocks are traded under the ticker TMCI.
Is Treace Medical Concepts stock price growing?▼
TMCI stock has fallen by -5.58% compared to the previous week, the month change is a +6.8% rise, over the last year Treace Medical Concepts has showed a -24.79% decrease.
What is Treace Medical Concepts market cap?▼
Today Treace Medical Concepts has the market capitalization of 285.44M
When is the next Treace Medical Concepts earnings date?▼
Treace Medical Concepts is going to release the next earnings report on August 11, 2026.
What were Treace Medical Concepts earnings last quarter?▼
TMCI earnings for the last quarter are -0.28 USD per share, whereas the estimation was -0.31 USD resulting in a +9.09% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Treace Medical Concepts revenue for the last year?▼
Treace Medical Concepts revenue for the last year amounts to 212.69M USD.
What is Treace Medical Concepts net income for the last year?▼
TMCI net income for the last year is -59M USD.
How many employees does Treace Medical Concepts have?▼
As of July 16, 2026, the company has 450 employees.
In which sector is Treace Medical Concepts located?▼
Treace Medical Concepts operates in the Health & Wellness sector.
When did Treace Medical Concepts complete a stock split?▼
Treace Medical Concepts has not had any recent stock splits.
Where is Treace Medical Concepts headquartered?▼
Treace Medical Concepts is headquartered in Ponte Vedra, United States.